Biotika a.s. (BSSE: 1BSL01AE)
Health Care · Pharmaceuticals · SK
€—
— today · — 1Y
Biotika a.s. (BSSE: 1BSL01AE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.81M.
trading between 7.00 and 23.00.
Tweenvest scores Biotika a.s. across four factors: quality 62/100, value 68/100, growth 60/100. Its strongest factor is value.
1BSL01AE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.81M
- Revenue (TTM)
- $21.31M
- P/E
- —
- EPS
- -1.70
- Dividend yield
- —
- Beta (5Y)
- 0.03
- 52-week high
- €23.00
- 52-week low
- €7.00
- Avg volume (3M)
- —
- Shares outstanding
- 700.00K
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lipocine Inc.NasdaqCM: LPCN | $14.18M | $1.72 | -16.10% |
| Panchsheel Organics LimitedBSE: 531726 | $14.04M | Rs103.15 | +0.29% |
| Pharma Equity Group A/SCPSE: PEG | $14.01M | Dkr0.08 | -2.06% |
| Parnax Lab LimitedBSE: 506128 | $13.89M | Rs117.00 | +1.74% |
| Yi Po International Holding LimitedOTCPK: YBZN | $13.77M | $— | — |
| Tvardi Therapeutics, Inc.NasdaqCM: TVRD | $13.74M | $1.03 | -10.43% |
| WooGene B&G Co., LtdKOSDAQ: A018620 | $13.72M | ₩2,660.00 | -0.19% |
| Citius Pharmaceuticals, Inc.NasdaqCM: CTXR | $13.71M | $0.50 | -6.06% |
Figures last refreshed Oct 11, 2026.